0001415889-23-007490.txt : 20230505
0001415889-23-007490.hdr.sgml : 20230505
20230505182554
ACCESSION NUMBER: 0001415889-23-007490
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230503
FILED AS OF DATE: 20230505
DATE AS OF CHANGE: 20230505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cote Timothy R.
CENTRAL INDEX KEY: 0001799061
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 23895385
MAIL ADDRESS:
STREET 1: 3529 TILDEN STREET, NW
CITY: WASHINGTON
STATE: DC
ZIP: 20008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
3
1
form3-05052023_100544.xml
X0206
3
2023-05-03
0
0000812796
SOLIGENIX, INC.
SNGX
0001799061
Cote Timothy R.
C/O SOLIGENIX, INC.
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
true
false
false
false
Common Stock
25317
I
Silk Road Therapeutics, Inc.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported units for purposes of Section 16 or for any other purpose.
/s/ Timothy R. Cote
2023-05-05